Speaker of the US House of Representatives Nancy Pelosi held a brief press availability with Chairman Charles Rangel, Chairman Henry Waxman, Chairman George Miller and Chairwoman Louise Slaughter following their meeting with President Barack Obama at the White House to discuss health care legislation and the reconciliation between the House and Senate versions of bills that have been passed in the respective Chambers (The Pharma Letters passim).
Following this, she commented: "We've had a very intense couple of days with meetings in our leadership, meetings with our staff. After our leadership meeting this morning, our staffs engaged with the Senate and the Administration's staff to review the legislation, suggest legislative language. I think we're very close to reconciliation, respectful of the challenges - policy and otherwise - in the House and in the Senate.'
During the press meeting, she was asked to mention a couple things for which she is hoping, to which she responded: 'What we're talking about is affordability and accountability. And I think that in both of the bills, the makings for great legislation is evident and present in both bills. So, it's not a question of adopting this or that. It's about addressing and meeting the needs of the American people - that this be affordable for the middle class - and to do that we have to hold the insurance companies accountable. Any legislation would have to be judged as to how it did that. Again, with the third 'A' - providing affordable access to affordable, quality health care at lower cost for the American people.'
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze